mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0001 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0001 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0002 |
mRNA |
GMX-1778 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |
mRNA |
BRD-K33514849 |
CTRPv2 |
pan-cancer |
AAC |
0.43 |
0.0002 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |
mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0002 |
mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0003 |
mRNA |
MLN2480 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.0004 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.0004 |